Hydrogel-based Drug Delivery Product(s) for Traumatic Brain Injury
ID: DHA242-003Type: BOTH
Overview

Topic

Hydrogel-based Drug Delivery Product(s) for Traumatic Brain Injury

Agency

Department of DefenseN/A

Program

Type: SBIRPhase: BOTHYear: 2024

Topic Link

https://www.sbir.gov/node/2608937

Additional Information

https://www.defensesbirsttr.mil/SBIR-STTR/Opportunities/
Timeline
  1. 1
    Release Apr 17, 2024 12:00 AM
  2. 2
    Open May 15, 2024 12:00 AM
  3. 3
    Next Submission Due Jun 12, 2024 12:00 AM
  4. 4
    Close Jun 12, 2024 12:00 AM
Description

The Department of Defense (DOD) is seeking proposals for a hydrogel-based drug delivery product for traumatic brain injury (TBI). The objective is to develop a biodegradable hydrogel system that can seal open-skull fractures or penetrating TBIs and release hemostatic agents, antimicrobials, and drugs to prevent brain swelling and herniation. The product should be easily administered by combat medics and have the potential for self or buddy-administration in austere settings. The proposal should include proof-of-concept for a hydrogel-based drug delivery platform in Phase I and pre-clinical in vivo exploratory studies in Phase II. The performer should also develop a transition plan for operational capability and demonstrate the potential for civilian use. The performer's transition plan should include a clinical development plan, product development plan, and a business case for commercialization. The deadline for proposal submission is June 12, 2024. For more information, visit the DOD SBIR website.

Files
No associated files provided.
Similar Opportunities
DOD SBIR 24.4 Annual - Medical Payloads for Army Robotic Platforms
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the development of medical payloads for Army robotic platforms. The objective is to create a modular medical mission payload that can carry heavy, climate-controlled containers to resupply blood and perform casualty evacuation (CASEVAC) with attachability to ground and air robotic/autonomous platforms. Currently, blood delivery, medical resupply, and CASEVAC are conducted by convoys of crewed vehicles, which can be limited in reaching the front line. The goal is to develop a medical multi-mission, modular payload that can be employed by robotic ground and air platforms. The payloads should comply with Safe Ride Standards for casualty evacuation using unmanned aerial vehicles (UAV), Robotics and Autonomous Systems, Ground (RAS-G), and modular payload design standards (Mod Payload). They should also be climate-controlled, collapsible, and capable of maintaining blood temperature between one and 10 degrees centigrade. The proposal should consider cost, and only Direct to Phase II (DP2) proposals will be accepted. The project duration includes Phase I, where a preliminary design of the payload should be formulated, Phase II, where the design is refined and a Technology Readiness Level (TRL) 5-6 system is created, and Phase III, which focuses on commercialization objectives. The solicitation is open until March 31, 2025. For more information, visit the [SBIR topic link](https://www.sbir.gov/node/2484469) or the [solicitation agency URL](https://www.defensesbirsttr.mil/SBIR-STTR/Opportunities/).
DOD SBIR 24.4 Annual - Sample Collection and Processing Methods to Support Battlefield Wound Infection Diagnostics (Direct to Phase II)
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for a Small Business Innovation Research (SBIR) program focused on the topic of "Sample Collection and Processing Methods to Support Battlefield Wound Infection Diagnostics (Direct to Phase II)". The Defense Health Agency is the branch responsible for this topic. The objective is to develop a simple-to-use sample collection and processing method capable of preparing an adequate specimen for the identification and accurate detection of specific fungal and/or bacterial species commonly associated with complex battlefield wound infections. The technology should be suitable for use in far-forward deployed environments. The current diagnostic capabilities for battlefield wound infections are limited and time-consuming, resulting in delays in treatment and medical intervention decisions. The proposed technology should enable rapid diagnosis (less than 2 hours) at the point of injury, improving patient outcomes and reducing morbidity and mortality. The technology should be compatible with wet/dry environments, require minimum logistical support, and be stable in long-term storage. It should also be easy to use with little training and provide unambiguous primary output. The technology must include a plan for FDA clearance and should align with CLIA-waived complexity standards. The SBIR program consists of three phases: Phase I focuses on demonstrating scientific and technical feasibility, Phase II involves refining the technology and integrating it with a rapid diagnostic platform, and Phase III aims to secure FDA approval and transition the technology for commercial use in both civilian and military settings. The proposal submission deadline is March 31, 2025. More information can be found on the grants.gov website or the DOD SBIR/STTR Opportunities page.
DOD SBIR 24.4 Annual - Medical Payloads for Army Robotic Platforms
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the development of medical payloads for Army robotic platforms. The objective is to create a modular medical mission payload that can carry heavy, climate-controlled containers to resupply blood and perform casualty evacuation (CASEVAC) with attachability to ground and air robotic/autonomous platforms. Currently, blood delivery, medical resupply, and CASEVAC are conducted by crewed vehicles, which can be challenging in reaching the front line. The goal is to develop a medical multi-mission, modular payload that can be employed by robotic ground and air platforms. The payloads should comply with Safe Ride Standards for casualty evacuation using unmanned aerial vehicles (UAV), Robotics and Autonomous Systems, Ground (RAS-G), and modular payload design standards (Mod Payload). They should also be climate-controlled, collapsible, and capable of maintaining blood temperature between one and 10 degrees centigrade. The proposal should consider cost, and only Direct to Phase II (DP2) proposals will be accepted. The Phase II deliverables include refining the preliminary design, creating a Technology Readiness Level (TRL) 5-6 modular medical mission payload, and demonstrating the payload's performance at a vendor-provided, government-approved location. Phase III involves pursuing commercialization objectives, developing a manufacturing-ready product design, and engaging in laboratory or operational testing. The keywords for this solicitation are UAS, UAV, Medical Payloads, Resupply, CASEVAC, and UGV. For more information, visit the DOD SBIR 24.4 Annual solicitation notice on grants.gov.
DOD SBIR 24.4 Annual - Sample Collection and Processing Methods to Support Battlefield Wound Infection Diagnostics (Direct to Phase II)
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for a Small Business Innovation Research (SBIR) program focused on the topic of "Sample Collection and Processing Methods to Support Battlefield Wound Infection Diagnostics (Direct to Phase II)". The Defense Health Agency is the specific branch of the DOD overseeing this topic. The objective is to develop a simple-to-use sample collection and processing method that can accurately detect specific fungal and bacterial species commonly associated with complex battlefield wound infections. The technology should be capable of preparing an adequate specimen for identification and detection in far-forward deployed environments. The current diagnostic capabilities for battlefield wound infections are limited and time-consuming, leading to delays in treatment and medical intervention decisions. The proposed technology should provide rapid diagnostics with a sample collection-to-result time of less than 2 hours, improving patient outcomes and reducing morbidity and mortality. The technology should be compatible with wet/dry environments, require minimum logistical support, and be stable in long-term storage. It should also be easy to use with little training and provide unambiguous primary output. The technology must include a plan for FDA clearance and should align with CLIA-waived complexity standards. The SBIR program consists of three phases: Phase I focuses on demonstrating scientific and technical feasibility, Phase II involves refining the technology and integrating it with a rapid diagnostic platform, and Phase III aims to secure FDA approval and commercialize the technology for both civilian and military settings. The government may propose further harmonization of the technology with other relevant products to meet additional DoD requirements. The solicitation is open until March 31, 2025. More information can be found on the grants.gov website or the DOD SBIR/STTR Opportunities page.
DOD SBIR 24.4 Annual - Biomaterial Energy Dissipating Structures (BEDS)
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the topic "Biomaterial Energy Dissipating Structures (BEDS)" as part of the SBIR program. The Defense Advanced Research Projects Agency (DARPA) is specifically interested in developing novel energy-dissipating biomaterial structures to enhance materiel and equipment airdrop capabilities. The current technology, which uses honeycomb cardboard pads, has limitations that can reduce the effectiveness of airdropped equipment. DARPA is looking for new biomaterial structures that can dissipate high levels of energy per unit mass and meet specific performance metrics. The structures must be at least 98wt% wood or other biodegradable plant-based material, have low projected costs for full-scale production, and pass various dynamic crushing stress and rebound energy tests. The project will be conducted in two phases, with Phase I focusing on achieving the specified mechanical properties of the structures within a six-month timeframe. Phase II will involve scale-up and mechanical properties testing, with the option for further scale-up and mass production in Phase II Option I. The ultimate goal is to develop energy-dissipating structures that can be used not only in airdropped materiel protection but also in various commercial applications such as truck trailers, shipping containers, packaging material, and building material for temporary structures. The solicitation is currently open, and the application due date is March 31, 2025. For more information, visit the [SBIR topic link](https://www.sbir.gov/node/2651285) or the [solicitation agency website](https://www.defensesbirsttr.mil/SBIR-STTR/Opportunities/).